Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Key Problems Behind Teva's Lackluster 2013
Motley Fool
Sunday, September 15, 2013 - 12:19pm
tags:
Teva Pharmaceuticals
Sun Pharma gets USFDA nod for duodenal ulcer capsules
Hindu Business Line, India
Saturday, September 14, 2013 - 11:15am
tags:
Sun Pharma, Prevacid, generics
ViroPharma Skyrockets on Buyout Rumors
equities.com
Saturday, September 14, 2013 - 11:13am
tags:
ViroPharma, M&A
Making Sense of the Sunshine Act
Pharmexec
Saturday, September 14, 2013 - 11:08am
tags:
Physician Payment Sunshine Act
Should A Generic Lovaza Worry Amarin Longs?
Seeking Alpha
Saturday, September 14, 2013 - 11:07am
tags:
Amarin, Lovaza, generics
Raptor's Procysbi approved for rare disease in EU
PharmaTimes
Saturday, September 14, 2013 - 11:05am
tags:
Raptor Pharmaceuticals, procysbi, nephropathic cystinosis
3 Things You Need to Know from Keryx's Stifel Conference Presentation
Motley Fool
Saturday, September 14, 2013 - 11:02am
tags:
Keryx, chronic kidney disease, dialysis, hyperphosphatemia, Zerenex
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, September 14, 2013 - 11:01am
tags:
Neurocrine Biosciences, ChemoCentryx, GSK, Avanir
1 Drug Dramatically Reshaping Pancreatic Cancer Treatment
Motley Fool
Saturday, September 14, 2013 - 11:00am
tags:
Celgene Corporation, Abraxane, pancreatic cancer
3 Promising Stocks Targeting CTGF and Dermal Scarring
Wall St Cheat Sheet
Saturday, September 14, 2013 - 10:56am
tags:
dermal scarring, RXI-109, Alnylam, Pfizer, RXi Pharmaceuticals, EXC-001, ALN-TTR02
Unilife Strutting Over Sanofi Deal (video)
The Street
Saturday, September 14, 2013 - 10:53am
tags:
Unilife, Sanofi
Lixisenatide NDA Withdrawn by Sanofi
Yahoo/Zacks
Saturday, September 14, 2013 - 10:52am
tags:
lixisenatide, Sanofi, type 2 diabetes, diabetes
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, September 14, 2013 - 10:50am
tags:
Geron, Aratana, Kythera Biopharmaceuticals
Fallout From This Heart-Drug Failure
Motley Fool
Saturday, September 14, 2013 - 10:49am
tags:
Amgen, Omecamtiv Mecarbil, heart failure, Cytokinetics
Is Vivus a Rudderless Ship?
Motley Fool
Saturday, September 14, 2013 - 10:47am
tags:
Vivus, Qsymia, Arena Pharmaceuticals, Belviq, obesity, weight loss
Gilead Investors' Nightmare Scenario
Motley Fool
Saturday, September 14, 2013 - 10:45am
tags:
Gilead Sciences
4 Healthcare Stock Stories Making a Buzz On Friday
Wall St Cheat Sheet
Saturday, September 14, 2013 - 10:44am
tags:
Teva Pharmaceuticals, Ariad Pharmaceuticals, Alexion, Galena Biopharma
Data from Alexion's Soliris Study
Yahoo/Zacks
Saturday, September 14, 2013 - 10:41am
tags:
Alexion, acute antibody-mediated rejection, kidney transplants, transplant, Soliris
Regeneron Pharma Soars As Sanofi Mulls Doubling Stake
investors.com
Saturday, September 14, 2013 - 10:39am
tags:
Regeneron, Sanofi
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Saturday, September 14, 2013 - 10:38am
tags:
Amgen, Celgene, ONYX Pharmaceuticals, Keryx, Pluristem Therapeutics, NPS Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.